Cuba has two COVID-19 vaccine candidates in phase III of clinical trials after the regulatory authority on Thursday approved Abdala to pass to that stage.
The Havana-based Immunoessay Research Center informed that Cuba has a new Ultra Micro Analytical System, which allows detecting several diseases early, among them Covid-19, local press reported on Thursday.
The Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH) in the province of Holguín, the only one of its kind in Cuba, prioritizes the follow-up programs for its patients, amid the epidemiological contingency generated by COVID -19, widespread on the Caribbean island.